Clinical Trial Update: ASTERIX: Low Dose ASA and Nexium [Phase 3]

View source ↗

Summary

Phase 3 trial ASTERIX investigating low-dose aspirin and esomeprazole for gastroesophageal reflux disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Aspirin (low-dose) (acetylsalicylic acid)
• Nexium (esomeprazole)

Snippet

Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux | Phase 3 | Status: COMPLETED